Whereas the role of prototypic adipokines such as adiponectin or leptin in NAFLD is rather established (Figure 1 and Figure 2, and Table 1), the impact of many other adipokines is still unclear and paralleled by substantial conflicting findings, especially with respect to resistin and NAMPT. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.